Biogen: CEO Departing; Is This Drug Maker In Play?

Bloomberg News/Scott Eisen There is no shortage of big news out of Biogen (BIIB) today. The announcement that CEO George Scangos would be leaving in the coming months, comes as the drug maker topped second-quarter forecasts, provided an upbeat earnings outlook and unveiled a $5 billion share buyback. Biogen shares, down 14% this year through […]
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.